Jyong Biotech Ownership
$1.78
4.81%
Nasdaq, Nov 03, 04:00 pm EST.
Closed.
Why the stock moved Beta
Industry
Jyong Biotech Top Shareholders
| # | Holder | Shares | % of Shares Out | Change | Filing Date |
|---|---|---|---|---|---|
| 1 |
Perfect Minds Co Ltd
|
25.350m | 34.15% | +25.350m | Jun 17 2025 |
| 2 |
Laxton Investments Company Ltd
|
7.631m | 10.28% | +7.631m | Jun 17 2025 |
| 3 |
Linkage Gladden Enterprise Ltd
|
6.864m | 9.25% | +6.864m | Jun 17 2025 |
| 4 |
Peak Valley International Co., Ltd.
|
5.098m | 6.87% | +5.098m | Jun 17 2025 |
| 5 |
Honest Dynasty Ltd
|
2.344m | 3.16% | +2.344m | Jun 17 2025 |
|
1
Perfect Minds Co Ltd
|
34.15%
25.350m
|
|
2
Laxton Investments Company Ltd
|
10.28%
7.631m
|
|
3
Linkage Gladden Enterprise Ltd
|
9.25%
6.864m
|
|
4
Peak Valley International Co., Ltd.
|
6.87%
5.098m
|
|
5
Honest Dynasty Ltd
|
3.16%
2.344m
|
| The largest shareholders show who really holds influence: big institutional owners shape a stock's liquidity, and building or cutting positions can move the price. | |
| The 5 largest shareholders together hold 63.70% of Jyong Biotech, with Perfect Minds Co Ltd the biggest at 34.15%, followed by Laxton Investments Company Ltd (10.28%) and Linkage Gladden Enterprise Ltd (9.25%). |
Jyong Biotech Short interest
Powered by
| Short interest shows what share of a stock's freely tradable shares (float) is currently sold short, meaning held by investors betting on falling prices. A high or rising level can be read two ways: it reflects the skepticism of many market participants, but also carries upside potential. Because if the stock rises, short sellers have to buy back, which can push the price up even further. This effect is called a short squeeze. |
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
